Index of /main/pdf/poster

	Name	Last modified	Size	Description
	Parent Directory		-
	Overcoming IgE interference in PK and ADA assay of Omalizumab in the serum of asthma patients.pdf	2026-05-21 04:36	5.6M
	ELISA Assay for Determination of Bevacizumab (Pharmacokinetic), VEGF-A (Pharmacodynamic) and Immunogenecity Assesment.pdf	2026-05-21 04:36	4.7M
	Development and Validation of an Anti-Omalizumab Antibody Assay.pdf	2026-05-21 04:36	2.9M
	Challenges in Estimation of FSH for Pharmacokinectic Study by Architect i1000 (CMIA Based Clinical Lab Instrument) and Commercial Kits.pdf	2026-05-21 04:36	2.8M
	Development of a Highly Sensitive, Drug-Tolerant, and Target-Tolerant Competitive Ligand Binding Assay for Detecting Neutralizing Antibodies Against Omalizumab Using Dynabeads Aff.pdf	2026-05-21 04:36	2.0M
	Development of Acid Dissociation Bridging ELISA Method for Determination of Anti-Bavacizumab Antibodies.pdf	2026-05-21 04:36	1.2M
	Bioanalytical Comparability between Biosimilar (Test Drug) and Innovator (Reference Drug).pdf	2026-05-21 04:36	700K
	Challenges Using Standardised ELISA Methods for the Assessment of Specific IgG Antibody in Vaccine Trials.pdf	2026-05-21 04:36	594K
	Validation of a flow cytometry based whole blood Natural Killer (NK) cell cytotoxicity assay as Immunity marker.pdf	2026-05-21 04:36	548K
	Development and Validation of an Enzyme-linked Immunosorbent Assay (ELISA) for the quantification of Trastuzumab in Human Serum to Support Pharmacokinetics in Clinical Trial.pdf	2026-05-21 04:36	298K
	Bioanalytical Challenges in Developing and Validating a Biomarker Assay for Tissue Factor Pathway Inhibitor (TFPI) using Commercial Kit.pdf	2026-05-21 04:36	157K